INDBInternet News Database 2.5 Updated 1 min ago · 393 sources Show or hide images Light or dark

Amplia gets nod for new cancer drug trial ahead of US push

Save Like Comments Compare coverage
Image from The Sydney Morning Herald

Summary

Amplia Therapeutics has received ethics approval for its ACCENT-Mini pancreatic cancer trial, paving the way to test daily doses of its narmafotinib drug alongside chemotherapy.

Description from The Sydney Morning Herald.

Who is covering this

  1. The Sydney Morning Herald Leans left Factuality: High AU
    Amplia gets nod for new cancer drug trial ahead of US push

    Amplia Therapeutics has received ethics approval for its ACCENT-Mini pancreatic cancer trial, paving the way to test daily doses of its narmafotinib drug alongside chemotherapy.

Comments

Comments need JavaScript.